Texas Democratic Senate candidate James Talarico has introduced a new initiative designed to dismantle alleged healthcare monopolies and decrease the cost of prescription drugs. He is launching this plan in conjunction with entrepreneur Mark Cuban.

Talarico, a current member of the Texas House of Representatives, is competing against Attorney General Ken Paxton in a highly anticipated Senate race for the 2026 election cycle. Talarico and Cuban are scheduled to participate in a live event and podcast recording in Fort Worth on Saturday to further discuss their plan.

"Mark and I are in agreement that it's time to dismantle the 'Big Medicine' monopolies that govern our flawed healthcare system," Talarico stated. "Healthcare corporations are exploiting us, inflating premiums, and profiting from our suffering. This plan aims to break up monopolies, alleviate medical debt, lower prescription drug prices, and ensure that doctors, not insurance companies, determine the medications their patients need."

Talarico is striving to become the first Democrat to win a statewide election in Texas since 1994. Securing this seat could be crucial for the Democratic party's bid to regain control of the Senate from Republicans. The Cook Political Report rates the race as a "toss-up," and recent polls indicate a close contest between Talarico and Paxton.

Across the nation, Democrats have emphasized the issue of the cost of living in their campaigns leading up to the November elections, criticizing President Donald Trump and the Republican-controlled Congress for policies they contend have negatively impacted the economy and increased prices.

Talarico is applying a similar approach to healthcare, asserting that industry consolidation is driving up the costs of health insurance and medical care. He highlights the trend of small, physician-owned practices being acquired by larger hospital systems, and the substantial revenue growth of major insurance companies.

He cited reports indicating that 90% of hospital beds are controlled by large hospital systems. Furthermore, three major pharmacy benefit managers—CVS Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum RX—are responsible for processing approximately 80% of all prescriptions nationwide.

In announcing the plan, Talarico expressed his support for antitrust legislation targeting vertically integrated healthcare conglomerates, including pharmacy benefit managers, insurance companies, and hospital networks.

The proposed legislation would prohibit PBMs from concealing pricing data, incentivize the development and approval of generic drugs, and establish caps on out-of-pocket medical expenses.

Representatives from the American Hospital Association and AHIP, which represent hospitals and health insurance providers respectively, have not yet responded to requests for comment.

Greg Lopes, a spokesperson for the Pharmaceutical Care Management Association, the trade group for PBMs, stated that PBMs are the only entities in the drug supply chain actively reducing prescription drug costs. He argued that there is no evidence suggesting that vertically integrated plans lead to increased expenses.

"American patients and families find our healthcare system's fragmentation and complexity highly frustrating, and this legislation would exacerbate that problem, leading patients into a more convoluted system of disjointed care," Lopes commented.

Mark Cuban, the billionaire entrepreneur who founded the Mark Cuban Cost Plus Drug Company in 2022, which aims to lower the cost of generic prescription drugs by bypassing PBMs and negotiating directly with pharmaceutical manufacturers, has spoken positively of Talarico.

In a recent podcast appearance, Cuban described Talarico as "honest" and someone who "will do the right thing instead of the politically expedient thing."

Cuban stated that Talarico's healthcare plan "will break up healthcare monopolies and lower the price of medicine."

"I have dedicated significant effort to reducing healthcare costs for everyone – politicians in Washington have not. Regardless of whether you are a Republican, Democrat, or independent, everyone desires more affordable, higher-quality healthcare. James's plan will achieve precisely that, which is why I am supporting it," Cuban added.

---

English Translation

Texas Senate Hopeful Talarico Teams with Mark Cuban on Plan to Break Up Healthcare 'Monopolies'

Texas Democratic Senate candidate James Talarico has unveiled a new plan, first shared with CNBC, to dismantle what he claims are healthcare monopolies and reduce the cost of prescription drugs. He is launching this initiative in partnership with entrepreneur Mark Cuban.

Talarico, a member of the Texas House of Representatives, is challenging incumbent Attorney General Ken Paxton in one of the most closely watched Senate races of the 2026 election cycle. Talarico and Cuban are set to appear together for a live event and podcast recording in Fort Worth on Saturday to discuss the plan.

"Mark and I agree it's time to break up the Big Medicine monopolies that control our broken healthcare system," Talarico said in a statement to CNBC. "Healthcare corporations are ripping us off — jacking up premiums and profiting off our pain. This plan will break up monopolies, lower medical debt, bring down the cost of prescription drugs, and ensure doctors decide what medication their patients need — not insurance companies."

Talarico is aiming to become the first Democrat elected statewide in Texas since 1994, in a seat that could be crucial for the party to win control of the Senate from Republicans. The Cook Political Report with Amy Walter rates the race a "toss-up," and recent polling shows Talarico and Paxton neck-and-neck.

Democrats nationwide have emphasized a cost-of-living message heading into the November election, criticizing President Donald Trump and the GOP-controlled House and Senate for enacting policies they say have harmed the economy and driven up prices.

Talarico is taking a similar approach on healthcare, arguing that consolidation is leading to rising health insurance and care costs; the acquisition of small, physician-owned practices by larger hospital groups; and skyrocketing revenues for large insurance companies.

He cited recent reports indicating that 90% of all hospital beds are controlled by large hospital systems. Additionally, just three pharmacy benefit managers — CVS Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum RX — process roughly 80% of prescriptions nationwide.

In an announcement of the plan, Talarico voiced his support for antitrust legislation that he said would target vertically integrated health-care conglomerates, such as pharmacy benefit managers, insurance companies, and hospital networks.

The proposed legislation would bar PBMs from hiding pricing data, create incentives to develop and approve generic drugs, and institute caps on out-of-pocket costs, according to the announcement.

Representatives from the American Hospital Association and AHIP, the trade groups representing hospitals and health insurance providers, did not immediately respond to a request for comment.

Greg Lopes, a spokesperson for the Pharmaceutical Care Management Association, the trade group representing PBMs, said in a statement that "PBMs are the only part of the drug supply chain lowering prescription drug costs." He argued there is no evidence that vertically-integrated plans lead to higher costs.

"One of the things American patients and families most dislike about our health care system is how fragmented and complex it is, and this legislation would only make that problem far worse — sending patients into a deeper maze of discontinuous care," Lopes said.

Cuban, the billionaire entrepreneur who in 2022 founded the Mark Cuban Cost Plus Drug Company, which focuses on lowering the consumer cost of generic prescription drugs by cutting out PBMs and negotiating directly with pharmaceutical manufacturers, has spoken favorably of Talarico.

In a recent appearance on the 'Pivot' podcast, Cuban called Talarico "honest" and said he would "do the right thing instead of the politically expedient thing."

In a statement, Cuban said Talarico's healthcare plan would "break up healthcare monopolies and lower the price of medicine."

"I've spent a long time working to reduce the cost of healthcare for everybody – politicians in Washington have not. Whether you're a Republican, Democrat, or an independent – you want more affordable, better quality healthcare. The plan James has put together will accomplish exactly that, which is why I am supporting it," Cuban continued.